MBL files first ANDA in eCTD format for BORTEZOMIB injection 3.5 MG/VIAL with USFDA. R&D team internally develops API, Shivalik Rasayan Ltd files DMF with USFDA. MBL authorised to use API for manufacturing injection. SEBI (LODR) Regulations, 2015 requirements met. Shares up 5.12% to Rs 755.30.

Medicamen Biotech’s USFDA filing sparks 5.12 per cent surge in shares

Uniphos Enterprises Ltd, Shivalik Rasayan Ltd, Medicamen Biotech Ltd and Peninsula Land Ltd are among the other gainers in the BSE’s ‘B’ group today, 26 August 2022.

Aarvee Denims & Exports Ltd leads gainers in ‘B’ group

#CNBCTV18 #ShivalikRasayan #ShivalikRasayanNews #BusinessNews #ShareMarketToday #Nifty #Sensex

Shivalik Rasayan is today's stock idea for profit from Moneycontrol Pro. Anubhav of moneycontrol.com joins in to share more about this stock which she is closely tracking.


CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

For latest news and updates visit our Website: https://bit.ly/2YbpXBM
Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

Shivalik Rasayan Share: Today's Stock Idea For Profit From Moneycontrol Pro |

The promoter acquires 10218 equity shares 0.09% through open market sale to increase its stake to 5118711 (41.90%) in the company.

Medicamen promoter Shivalik Rasayan increases stake in company

Patel Integrat(PP), Shivalik Rasayan, Asian Oilfield, Next Mediaworks and MTNL, hit their fresh 52-week highs during the day.

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Patel Integrat(PP), Shivalik Rasayan, Asian Oilfield, Next Mediaworks and Vodafone Idea, hit their fresh 52-week highs at 11:20AM.

Stock market update: Stocks that hit 52-week highs on NSE

Shivalik Rasayan consolidated net profit rises 82.14% in the September 2021 quarter

Board of Shivalik Rasayan approves preferential allotment of shares and warrants

Shivalik Rasayan is engaged in providing agrochemicals.

Shivalik Rasayan submits another CEP to EDQM, Europe; Stocks ends 2% higher

The CEP was in eCTD format for BUSULPHAN to EQDM.

Shivalik Rasayan stock trades flat after submitting first CEP for Europe

Shivalik Rasayan consolidated net profit rises 55.94% in the December 2020 quarter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Shivalik Rasayan Limited is a manufacturer of organ phosphorous (OP)-based insecticides and chemicals. It also manufactures organophosphate insecticides, such as Dimethoate Technical and Malathion Technical. 